RESEARCH DOSSIER
Child and Adolescent Counseling and Psychotherapy
Abstract. Child and adolescent counseling and psychotherapy are developmentally adapted psychological interventions that address emotional, behavioral, interpersonal, and functional difficulties in the context of changing capacities, family relationships, schools, and service systems. This fundamental research monograph reconstructs the historical formation of youth psychotherapy and synthesizes original randomized clinical trials, systematic reviews, meta-analyses, methodological work, and clinical guidelines, including evidence published through 2026. It evaluates cognitive and behavioral therapies, interpersonal approaches, family- and parent-mediated interventions, trauma-focused treatment, approaches to recurrent self-harm, and developmentally adapted digital care. It distinguishes treatment efficacy from causal mechanism, diagnostic remission from functional recovery, and intervention delivery from the quality of the service environment. The evidence supports meaningful benefits for defined youth conditions, particularly cognitive behavioral interventions for anxiety, while revealing substantial variation by diagnosis, comparison condition, reporter, treatment format, and follow-up. The synthesis identifies critical constraints involving adolescent assent, confidentiality, multi-informant assessment, safeguarding, inclusion of diverse youth populations, intervention fidelity, digital safety, and continuity of care. Its research agenda emphasizes active-treatment comparisons, process-level causal designs, long-term functioning, adverse-event monitoring, and equitable access. The method is a structured critical narrative synthesis, not a new experimental study or protocol-driven systematic review.
Keywords: child psychotherapy; adolescent psychotherapy; child counseling; youth mental health; developmentally adapted treatment; cognitive behavioral therapy; interpersonal psychotherapy; trauma-focused CBT; therapeutic alliance; parent-mediated interventions; family-based treatment; psychological assessment; multi-informant outcomes; assent and confidentiality; anxiety disorders; adolescent depression; self-harm; digital psychotherapy; treatment efficacy; clinical safety; implementation science; Artificial Era
Introduction and Scientific Scope
Child and adolescent counseling and psychotherapy comprise structured psychological interventions intended to reduce distress, alter impairing behavioral and emotional patterns, strengthen functioning, and support developmentally appropriate participation in family, school, peer, and community life. The research object is a treatment process involving a young person whose capacities, relationships, legal circumstances, and developmental tasks change over time. An intervention may address an identifiable psychiatric disorder, a pattern of persistent emotional or behavioral difficulties, a crisis, or psychological adjustment in the context of disability, loss, family disruption, or adversity. The scientific question is how intervention practices produce clinically meaningful changes in particular young people under specified conditions. The outcome may include anxiety symptoms, depression, self-harm recurrence, trauma-related difficulties, behavioral functioning, school attendance, family relationships, quality of life, and the young person's own appraisal of progress.
The category covers child- and adolescent-focused psychotherapy, caregiver-mediated interventions when their purpose is to improve youth outcomes, and systemic approaches coordinating the young person with caregivers or institutional settings. It spans individual, family, group, school-based, outpatient, community, and digitally supported treatment arrangements. Counseling denotes collaborative assessment, guidance, formulation, and psychological support; psychotherapy usually denotes a defined therapeutic approach delivered across sessions to achieve specified changes in distress or functioning. These labels overlap in actual services, and the most informative scientific classification follows the treatment operation, target problem, developmental population, and comparison condition rather than a provider's title.
The evidence base is unusually heterogeneous. The multilevel meta-analysis by Weisz (2017) combined 447 randomized youth psychotherapy studies and 30,431 participants, documenting an overall treatment benefit while demonstrating substantial variation by presenting problem and study conditions. The average effect provides a starting point for evaluating psychological intervention as a field. It cannot substitute for disorder-specific estimates, information on the comparison group, the informant reporting improvement, follow-up durability, or the feasibility of treatment in real-world services. Accordingly, this monograph evaluates clinical trial evidence, developmental mechanisms, treatment processes, and implementation conditions together.
The scope is deliberately treatment-centered. Descriptions of normal cognitive and social development matter here when they explain how psychotherapy can be adapted or assessed. Diagnostic classifications matter when they define trial populations and service responsibilities. Neurodevelopmental pathways, school pedagogy, pharmacology, and general family socialization become relevant where they alter the intervention or its measured effects. Specialized psychotherapy for trauma, eating disorders, suicide-related behavior, and other conditions is discussed as evidence for broader principles of youth treatment, with clinical decisions remaining dependent on condition-specific guidelines and professional judgment.
Research Method and Evidence Appraisal
This monograph uses a structured critical narrative synthesis of original randomized and comparative clinical studies, methodological contributions, systematic reviews, meta-analyses, and official professional guidelines. The review emphasizes identifiable studies in youth populations, research in ordinary service settings, longitudinal findings on treatment processes, and work on measurement, consent, safety, and access. Its organization is based on research questions and explanatory relationships rather than an exhaustive database retrieval protocol. It is therefore a scholarly narrative synthesis, not a registered systematic review, network meta-analysis, new clinical trial, or source of original patient-level data.
A hierarchy of causal warrant governs interpretation. Random allocation can support inference about an assigned treatment contrast when allocation and follow-up are adequately preserved. It does not prove that the explanatory mechanism proposed by the treatment manual caused improvement. A mediated relationship can be suggestive but requires temporal measurement, confounding assumptions, and preferably an intervention that selectively changes the candidate mechanism. Prospective cohort studies and routine clinical data can reveal patterns of engagement and prognostic variation; their interpretations remain conditioned by selection, case complexity, and service context. Qualitative evidence informs feasibility, meaning, and acceptability, which are important outcomes in themselves but should be linked carefully to claims about symptom reduction.
Evidence grading in this account considers comparison quality, randomization, sample size, baseline severity, reliability of measurement, masking of outcome assessment where feasible, attrition, treatment fidelity, differences across reporters, statistical uncertainty, follow-up time, and risk of selective publication. James (2020) illustrates why this matters: cognitive behavioral therapy for youth anxiety performs strongly against waiting-list conditions, while comparisons with other active care and conclusions about acceptability have different levels of certainty. For youth psychotherapy, adverse outcomes and potential treatment burdens need explicit observation alongside efficacy.
This review distinguishes historical frameworks from presently tested treatment claims. A therapeutic school may establish concepts that shaped clinical practice while its proposed explanatory mechanism remains empirically unsettled. Research conclusions are also indexed to population, setting, period, diagnostic approach, and technology. Recent digitally mediated interventions receive separate scrutiny because changes in therapist contact, access, family involvement, and outcome collection alter the treatment being evaluated. References identify the studies used for material claims; where evidence from a source is available only through a published abstract, the account is restricted to its reported design and outcomes.
Historical Formation of Child and Adolescent Psychotherapy
Psychological treatment with young people developed through several interacting traditions. Early child guidance clinics and mental hygiene services connected emotional disturbance, parenting, school behavior, and social conditions, while child psychoanalysis and therapeutic play established clinical attention to developmental symbolism and relational experience. In the twentieth century, Anna Freud and Melanie Klein gave different theoretical descriptions of play, internal conflict, and the treatment relationship. Later nondirective and child-centered approaches made the quality of therapeutic engagement and the child's agency central clinical questions. Their historical significance lies in how they made development and relationship part of the therapeutic encounter; contemporary evidentiary appraisal requires separate tests of their mechanisms and outcomes.
The growth of experimental learning research, behavior therapy, social learning approaches, and cognitive therapy brought more explicit procedures, measurable targets, and controlled outcome comparisons into treatment with children and adolescents. Parent-management interventions investigated contingencies, reinforcement, and reciprocal escalation in disruptive behavior. Exposure-based programs assessed the reduction of avoidance in anxiety. Adolescent interpersonal therapies focused on role transitions, grief, and interpersonal disputes. These traditions expanded the possible unit of intervention: sometimes change is targeted directly in the child's thoughts or behavior, and sometimes the primary intervention acts on parenting practices or family interactions that sustain the problem.
An important empirical milestone was Kendall (1994) of cognitive-behavioral treatment for anxious children. Later large, multisite investigations, including the Walkup (2008), broadened comparisons between psychotherapy, pharmacotherapy, combination care, and placebo conditions. For adolescent depression, controlled trials by Mufson (1999) and the Treatment for Adolescents With Depression Study (TADS) Team. (2004). Fluoxetine (2004) helped define the evidence for interpersonal and cognitive-behavioral approaches. Treatment science increasingly tested defined manualized programs across sites and measured outcomes beyond clinician impressions.
The subsequent research agenda shifted toward comparative effectiveness, transportability, modularity, parent and youth engagement, and the conditions of ordinary clinical practice. Chorpita (2009) systematized treatment elements across randomized studies, while Weisz (2012) directly compared modular, standard, and usual-care approaches for common youth problems in community settings. This historical trajectory produced a science in which treatment technique, patient heterogeneity, developmental context, and service organization must be analyzed simultaneously.
Development as a Condition of Psychological Treatment
Developmental level shapes how psychological difficulties are communicated, assessed, and modified. Young children often express distress through behavior, bodily complaints, play, separation patterns, and interactions with caregivers. Their treatment generally depends on adults to arrange appointments, implement changes at home, and help interpret interpersonal situations. Adolescents may be capable of sophisticated reflection, planning, and collaborative problem solving while negotiating expanding autonomy, peer affiliation, identity concerns, privacy, and family authority. Chronological age is therefore a useful but incomplete guide; language ability, cognitive capacity, social context, executive functioning, and preferences also affect the treatment design.
The same intervention label may describe different procedures across developmental periods. Cognitive restructuring with a school-age child may employ short concrete examples, behavioral rehearsal, drawings, and caregiver support, whereas work with an older adolescent may use detailed examination of expectations, values, and social interpretations. Exposure-based treatment depends on the individual's understanding of the task, control over participation, and opportunities to generalize learning across home and school. In younger children, parent-mediated reinforcement and modeling can be particularly important. Developmental adaptation should specify the actual change in therapeutic operations, then test whether it improves effectiveness, retention, acceptability, or functional outcomes.
A further complication is that symptoms and normative developmental transitions may resemble one another. A transient period of social withdrawal, emotional volatility, or oppositional behavior cannot by itself establish a psychiatric disorder. Clinical significance requires attention to persistence, context, impairment, risk, and developmental expectations. Conversely, attributing severe impairment entirely to a developmental phase risks withholding needed care. Effective assessment joins the young person's perspective with observations across settings and, where appropriate, diagnostic evaluation. The developmental trajectory also influences the endpoint: a reduction in symptom scores may be accompanied by a slower return of peer participation or school engagement.
Psychotherapy can itself affect developmental opportunities. Successful treatment may permit a child to attend school, participate in ordinary social situations, sleep independently, or reestablish relationships that provide learning experiences. Conversely, repeated appointments, family financial strain, confidentiality conflicts, and an inaccessible care setting can introduce burdens. A comprehensive evaluation therefore asks whether treatment enables valued daily activities and preserves meaningful choices in the young person's environment. The central analytic proposition is that youth psychotherapy is both an intervention on psychological symptoms and a coordinated effort to restore or extend developmentally relevant functioning.
Consent, Assent, Confidentiality, and Professional Accountability
Child and adolescent treatment takes place within a triadic ethical field involving the young person, parents or other legal decision-makers, and clinical professionals; schools and public agencies may also participate. Consent authority varies by age, clinical circumstance, service type, and jurisdiction. Assent refers to the young person's developmentally appropriate affirmative participation and understanding when another person holds legal consent authority. A legally valid permission process and a clinically meaningful alliance are related but separate requirements. The young person needs an intelligible explanation of the purpose of meetings, expected activities, possible benefits and burdens, confidentiality limits, and available choices.
Confidentiality is central to therapeutic trust, particularly in adolescence. A clinician ordinarily needs a clearly articulated policy describing what may remain private, what information will be shared with caregivers, and what safety or mandatory-reporting circumstances require disclosure. Those boundaries should be explained before sensitive disclosures, then revisited as clinical needs change. The extent of caregiver access to records and the rights of minors differ across legal systems; general claims about universal parental rights or absolute adolescent privacy would be misleading. Collaboration with a young person over appropriate information-sharing can preserve both safety and agency.
A research-informed ethics framework includes the potential asymmetry of authority between adults and children. Young people may agree to treatment to satisfy parents or schools; they may hesitate to report that an intervention feels frightening, embarrassing, irrelevant, or ineffective. Clinicians therefore need to monitor participation and comprehension, provide space for disagreement, and evaluate whether consent remains meaningful as treatment changes. For research participation, separate ethics oversight, privacy protection, and developmentally appropriate recruitment apply. Electronic records, telehealth platforms, and shared outcome dashboards introduce further data-governance questions about access, storage, retention, and disclosure.
Safety duties vary according to the young person's condition. A service encountering self-harm, abuse, severe functional decline, or acute risk must arrange appropriate assessment and follow local safeguarding and emergency procedures. National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) emphasizes individualized psychosocial assessment and warns against using risk scales or rigid low–medium–high categories to predict suicide or determine access to care. These standards imply a recurring clinical responsibility: protecting the child's welfare and maintaining reliable care pathways while honoring developmental participation and contextual dignity.
Assessment, Formulation, and Multi-Informant Evidence
Assessment identifies the current problem, onset, severity, duration, impairment, relevant strengths, family and school context, previous support, and conditions that maintain or alter symptoms. A formulation is a revisable account connecting these observations to hypotheses about maintaining processes and change opportunities. In youth work the formulation also considers caregivers' capacities and constraints, peer settings, learning demands, exposure to stressors, and the interaction between individual vulnerability and environmental response. Good formulation guides explicit target selection, treatment choice, and outcome measurement rather than remaining a narrative diagnosis detached from clinical decisions.
Multi-informant assessment is essential because young people, caregivers, teachers, and clinicians observe different settings and may use different standards for evaluating difficulties. De Los Reyes (2005) showed why discrepancies among informants should be investigated as psychologically informative rather than simply averaged away or treated as measurement error. A child may describe intense internal anxiety while a teacher sees minimal classroom impairment; a caregiver may report disruptive behavior at home that is absent at school. Such divergence can reflect situational expression, relationship dynamics, access to private experiences, measurement properties, and expectations.
Baseline and repeated assessments should distinguish symptoms from functioning. A validated anxiety scale may track fear and avoidance, but treatment goals also may require attendance records, participation in feared situations, family functioning, sleep, or personally defined activities. A depression scale may detect changes that are not yet visible in academic performance or social connection. The timing of measurement matters: brief fluctuations can reflect examination periods, school holidays, conflicts, or transient safety events. Reliable interpretation benefits from repeated observation, prespecified outcomes, and attention to both improvement and deterioration.
Screening is a related but distinct activity. In primary care, the U.S. Preventive Services Task Force. (2022). Screening for anxiety in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA (2022) recommended screening for anxiety among children and adolescents aged eight to eighteen while identifying insufficient evidence for younger children. A positive screen signals a need for clinical assessment; it is neither a complete diagnostic determination nor a treatment plan. Diagnostic interviews and validated measures support decisions when interpreted in relation to cultural and language context, developmental expectations, and the young person's actual impairment. Research design must also account for reporter-related bias when treatment participants know which intervention they received.
Outcomes, Follow-Up, and the Meaning of Improvement
The scientific quality of a psychotherapy study depends on what is counted as improvement. Symptom reduction, diagnostic remission, reliable change, reduced self-harm, restored school participation, improved relationships, satisfaction, and treatment completion answer different questions. Diagnostic remission may be demanding and clinically informative, yet a child with ongoing symptoms can gain meaningful functioning. Conversely, apparent remission on a narrow scale may coexist with continuing distress in another setting. Good studies therefore distinguish their primary endpoint from supportive secondary endpoints and state the timing and informant used for each.
Treatment response is strongly affected by the comparison group. Waiting lists and minimal-contact controls differ from credible alternative psychotherapy, enhanced usual care, or active educational interventions. The Weisz (2017) illustrates that average efficacy is contingent on these methodological choices and on problem category. A carefully described effect size expresses the contrast actually evaluated in a particular evidence set; it should not be projected across all ages, diagnoses, populations, or treatment formats. Even when statistical improvement is established, the durability of gains requires separate follow-up evidence.
Attrition and missing outcomes have substantive meanings in youth care. A family may discontinue because treatment succeeded, was burdensome, felt unhelpful, conflicted with school, or became inaccessible. Analyses based exclusively on completers risk producing systematically optimistic results. Clinical trials should report allocation, attendance, loss to follow-up, treatment crossover, and reasons for discontinuation where known. Research using intention-to-treat principles and sensitivity analyses is generally more informative about real-world treatment assignment than an account limited to those who completed every session.
Follow-up assessment connects the intervention to developmental sustainability. Gains achieved through structured in-session tasks must eventually be practiced in ordinary contexts that change over time. A successful school transition, a new peer group, family upheaval, or renewed exposure to trauma can alter functioning after treatment ends. Thus treatment efficacy, relapse prevention, adaptive generalization, and service reaccess are complementary outcomes. A mature science of youth psychotherapy studies both the immediate treatment contrast and the young person's evolving environment in which change must be maintained.
Therapeutic Alliance, Trust, and Developmental Engagement
The therapeutic alliance in youth treatment comprises negotiated goals, workable tasks, and an interpersonal relationship in which the young person can participate. Alliance is complicated by the fact that a caregiver may have initiated treatment or may prioritize problems differently from the child. A young person can comply with appointments without endorsing the treatment goal, and a parent can endorse behavioral improvement while the child experiences the intervention as punitive. A formulation of alliance therefore assesses participation and perceived fairness from multiple perspectives. The relation between alliance and outcome is an empirical question, not a guarantee that an agreeable therapeutic relationship produces symptom change.
A review by Shirk (2011) synthesized research on alliance in child and adolescent psychotherapy and reported a modest positive association with outcome. That result supports the clinical relevance of cooperation and trust, while the predominantly correlational character of alliance data limits causal interpretation. Early symptom improvement may strengthen confidence in a clinician, and a well-matched intervention may simultaneously improve symptoms and perceived alliance. Future research needs repeated youth-specific alliance ratings, clear outcome time points, and analysis of reciprocal changes rather than a single retrospective relationship score.
Alliance with caregivers is also relevant when adults are asked to model, monitor, reinforce, or accommodate behavioral change. The therapist may need to sustain two interdependent working relationships with different preferences and concerns. A parent may require guidance about how to support exposure without increasing avoidance, whereas an adolescent may require a protected opportunity to speak about privacy, peer relationships, or conflict. Negotiating these roles can reduce opposition to treatment and support generalization. Evaluations should report which alliance was measured and whether it predicts attendance, skill practice, or independently assessed outcomes.
Ruptures occur when a young person feels misunderstood, coerced, criticized, or disconnected from the agreed goal. Their clinical management requires curiosity about the child's experience and explicit renegotiation of tasks where possible. A rupture may provide information about the treatment's appropriateness, the clinician's approach, family pressure, or an unrecognized safety concern. Research should examine whether such repair processes precede improvement and under which conditions they are beneficial. An association between alliance and outcome gives a reason to study these processes; it does not establish a single universal therapeutic mechanism.
Developmentally Adapted Cognitive and Behavioral Interventions
Cognitive and behavioral approaches provide a family of procedures aimed at changing maladaptive avoidance, reinforcement patterns, rigid expectations, unhelpful behavior sequences, and interpretations of events. Their appeal in youth research includes explicit treatment targets, observable practice tasks, and the ability to adapt procedures across ages. Psychoeducation can translate an emotional or behavioral model into language the child understands. Behavioral activation can structure engagement with valued activities; cognitive techniques can investigate predictions and beliefs; exposure can create opportunities to learn in previously avoided contexts. The empirical support for these techniques depends on the target condition and treatment package.
Exposure for anxiety asks a young person to approach feared but objectively manageable situations in a planned way while reducing safety behaviors that sustain avoidance. The method requires careful assessment of actual danger, the child's capacity, and the role of caregivers in providing realistic support. Learning may involve new expectations, tolerance of anxiety, increased behavioral flexibility, and revised interpretations of threat. Simply forcing participation would undermine assent and make the clinical procedure difficult to distinguish from coercive exposure to genuine risk. Evidence-based programs introduce graduated activities with collaborative rationale and outcome tracking.
Cognitive methods are often adapted using drawings, stories, concrete examples, coping statements, or role-play. A clinician can test a prediction by comparing what the young person expected with what occurred in an ordinary situation. For adolescents, collaborative examination may include social evaluation, future uncertainty, self-criticism, and identity-related beliefs. Developmental accessibility matters because a technically correct exercise that exceeds the child's language or reasoning capacity may be incomprehensible. Researchers should report how programs were adapted and whether the adaptation preserved their hypothesized active processes.
The James (2020), covering 87 randomized studies of CBT for youth anxiety, offers strong evidence of benefit against waiting-list conditions, with more limited certainty regarding comparisons with alternative active interventions. This distinction is essential when generalizing from specific programs to psychotherapy as a whole. Skills training, therapeutic contact, caregiver support, and expectancy may operate together. Component studies and more selective experimental contrasts are needed to explain how much improvement depends on any particular operation.
Parent-Mediated Treatment and Family Participation
Caregivers are frequently part of the mechanism by which therapy changes a child's daily circumstances. Parent participation may include learning to respond consistently to behavior, reducing reinforcement of avoidance, strengthening predictable routines, supporting emotion regulation, or participating in a family formulation. For younger children, a parent may deliver much of the intervention between sessions. In adolescents, caregiver involvement must be negotiated in relation to the young person's autonomy and confidentiality, as excessive surveillance can itself become a clinical obstacle. The optimal form of participation depends on target behavior, family resources, and the child's preferences.
Research on disruptive behavior provides a particularly clear rationale for parent-mediated approaches. Behavior may be shaped by reciprocal cycles involving child distress, parental demands, coercion, relief, and reinforcement. Parent training seeks to alter these contingencies by increasing positive engagement, predictable consequences, and effective communication. Eyberg (2008) reviewed the evidence for psychosocial treatments for disruptive behavior and identified well-supported behavioral and parent-focused approaches. Such programs are evaluated through changes in observable behavior, caregiver responses, and functioning across settings.
Family involvement can also assist anxiety and depression treatment, but it is not a uniform ingredient to be added regardless of circumstance. A caregiver may help a child practice a fear hierarchy, monitor daily activities, coordinate school attendance, or reduce conflict. In some families the caregiver is unavailable, overwhelmed, unsafe, or involved in the child's distress. Treatment design must then protect the young person and identify other reliable supports. Studies that simply code family participation as present or absent obscure the quality, intensity, and purpose of that involvement.
Family-based interventions for eating disorders illustrate a distinct clinical arrangement: caregivers may take a central practical role in nutritional rehabilitation within a structured therapeutic framework. In a randomized comparison of adolescents with anorexia nervosa, Lock (2010) compared family-based treatment with adolescent-focused individual therapy and reported differences at follow-up favoring family-based treatment on full remission. This finding belongs to a specific diagnostic population and protocol. It cannot justify a general assumption that intensive parental control benefits all adolescent problems.
Therapeutic Formats, Treatment Dose, and Engagement
Psychological treatment may be delivered individually, in groups, in family sessions, through parenting programs, or through coordinated school and community services. Format determines who can participate, what skills can be practiced, how confidentiality is maintained, and whether learning generalizes to daily routines. A group may provide opportunities for peer practice and normalization while also requiring safeguards against social exclusion and inadvertent disclosure. Family sessions allow observation of interaction patterns but may inhibit candid youth reports when sensitive topics concern caregivers. Individual sessions can protect privacy yet may have less direct leverage over household contingencies.
Treatment dose describes the quantity and timing of therapeutic contact, but a session count alone may fail to capture exposure practice, homework completion, caregiver implementation, digital contact, and service interruptions. Attendance is partly an outcome of intervention design. A clinician who simplifies instructions, identifies transportation barriers, or coordinates with school schedules may increase practical accessibility. Conversely, severe baseline symptoms, poverty, unstable housing, and fragmented services can make regular participation difficult. Analyses of dose–response relationships must consider that improvement can influence whether families continue attending.
Engagement should be distinguished from unquestioning compliance. Meaningful engagement includes understanding the proposed task, having opportunities to express disagreement, participating in agreed activities, and communicating what occurs between sessions. Adolescents may be especially sensitive to imposed treatment goals or information-sharing that bypasses them. Treatment planning can incorporate the young person's prioritized outcomes alongside clinician-assessed risk and family concerns. Shared decision processes are testable through attendance, alliance reports, goal concordance, experience sampling, and clinical outcome comparisons.
Dropout is a multidetermined event. Studies need to specify whether dropout means failure to attend a fixed number of sessions, unilateral termination, withdrawal from research, or discontinuation after early improvement. Those categories carry different implications for efficacy. Treatment completion rates are particularly difficult to compare across interventions when one program has fewer sessions or greater flexible contact. A rigorous synthesis reports the denominators, follow-up losses, and the assumptions used to handle missing data, while avoiding a presumption that every noncompleter has experienced treatment failure.
Modular Treatment, Transdiagnostic Problems, and Personalized Sequencing
Young people presenting for care frequently experience overlapping difficulties: fear and avoidance alongside low mood, irritability alongside school disengagement, and family conflict alongside emotional dysregulation. A treatment manual built around one narrowly defined disorder may capture only part of the formulation. Modular treatment approaches assemble evidence-informed components and permit sequencing based on a structured set of decision rules. Transdiagnostic approaches target processes such as avoidance, reinforcement, emotion regulation, or interpersonal conflict across diagnostic categories. Both are attempts to make established intervention principles more responsive to complex presentation.
In a randomized effectiveness study, Weisz (2012) tested modular and standard manualized treatment approaches, alongside usual care, for youth anxiety, depression, and conduct problems in community clinical services. The reported findings supported the modular approach on several outcomes in that setting. The investigation was especially important because it examined implementation in real treatment organizations rather than exclusively in specialist research clinics. Its inference concerns the particular modular design and comparators tested, not every possible form of individually tailored therapy.
Personalized sequencing can be treated as an explicit research problem. At one point, a young person may require stabilization, motivational work, or family coordination before direct exposure or behavioral activation becomes feasible. At another, persistent symptoms despite good attendance may indicate an incomplete formulation or a need for different treatment operations. An adaptive treatment strategy specifies assessment checkpoints and conditions for changing the intervention. Randomized adaptive designs and repeated outcome measurement can then examine whether a sequence improves outcomes beyond fixed treatment delivery.
A scientific account must distinguish customization from intuitive improvisation. Clinicians can vary treatment with considerable care yet inadvertently abandon an effective ingredient, increase burden, or shift goals without agreed criteria. Fidelity and flexibility are therefore both measurable. The research questions include which components were delivered, whether the sequence corresponded to symptom and functional changes, and how the treatment responded to dropout risk. The ultimate objective is to identify decision rules that are safe, interpretable, developmentally appropriate, and useful across different service contexts.
Psychological Mechanisms and the Question of Causal Change
Therapy theories propose mechanisms such as new fear learning, increased behavioral reinforcement, revised cognitive appraisals, greater emotion-regulation flexibility, healthier family contingencies, improved interpersonal functioning, or strengthened self-efficacy. These mechanisms operate at different explanatory levels. Some concern individual learning; others involve reciprocal social responses or environmental access. A therapy can produce benefit through several pathways, with one pathway supporting another. Scientific explanation requires a more precise claim than stating that a manual contains a technique associated with improvement.
A candidate mediator is a variable statistically located between treatment assignment and outcome; a mechanism is a proposed causal operation capable of producing the observed change. Treatment assignment may change a mediator without proving that the mediator is the necessary causal pathway. For example, exposure treatment may reduce avoidance and anxiety, but a third process may influence both. Likewise improved alliance may predict better outcome while early symptom improvement itself increases alliance. Temporal sequencing, experimental manipulation, and sensitivity to alternative explanations help distinguish mechanism from correlation.
In youth psychotherapy, family and school conditions produce particularly important interactions. A child who begins to approach feared situations may require a caregiver to modify reassurance practices and a teacher to support classroom participation. A depressed adolescent's increased activity may create new peer opportunities that improve mood, which then reinforces activity. These are dynamic processes with feedback loops. Their study may require repeated ratings, behavior observations, ecological momentary assessment, and multi-level models linking the young person to family and institutional environments.
Research should explicitly identify plausible adverse pathways as well. Excessive focus on symptom monitoring may intensify self-scrutiny for some individuals; poorly calibrated exposure can reduce engagement; family participation can compromise privacy; digitally delivered treatment can create data-security risk. These are hypotheses and context-dependent concerns requiring observation rather than automatic conclusions about a technique's safety. Mechanism research is most useful when it tests the intervention's intended effects, unintended consequences, and the conditions that alter both.
School and Peer Environments as Treatment Contexts
School is a major site of emotional, behavioral, and social functioning during childhood and adolescence. Attendance, learning demands, peer experiences, classroom structure, and relationships with teachers can affect symptoms and treatment opportunities. Anxiety may lead to avoidance of particular school situations; depression may reduce engagement; behavioral dysregulation may disrupt peer relationships and evoke disciplinary responses. These difficulties are often maintained by interactions among the young person, family expectations, school practices, and available services.
A school-informed formulation asks which environmental features are stressful, which are modifiable, and how therapeutic gains can be practiced there. Collaboration might involve agreed accommodations, predictable reentry plans, opportunities for gradual participation, or communication with a designated support professional. This collaboration requires lawful and ethically appropriate information-sharing. A classroom intervention and outpatient psychotherapy can have complementary goals without being methodologically interchangeable. Research needs to identify whether outcomes were measured by teachers, parents, youth reports, records, or blinded observers.
Peer relationships have a dual role. They can contribute to distress through exclusion, victimization, or conflict, and they can provide important opportunities for belonging and interpersonal learning. Group therapy sometimes uses peer interaction therapeutically; individual therapy may rehearse communication or coping skills for real encounters. Outcomes should include the quality and sustainability of peer participation when these are treatment targets. Merely reducing a symptom scale score does not establish that a young person has regained valued friendships or social confidence.
School and community services also introduce structural inequalities. Referral criteria, special education processes, workforce availability, travel demands, language access, and family work schedules shape who receives treatment and whose outcomes enter research datasets. Evaluating psychosocial interventions in educational settings therefore requires attention to equity, confidentiality, implementation feasibility, and the distinction between universal prevention programs and treatment for young people with identified clinical problems. Neither the school setting nor the use of a psychological curriculum automatically establishes a psychotherapy intervention.
Anxiety Disorders and Exposure-Based Psychological Treatment
Anxiety treatment offers one of the strongest evidence bases within child and adolescent psychotherapy. Problems commonly addressed include separation anxiety, generalized anxiety, social anxiety, specific phobias, and related patterns of avoidance. Treatment targets may involve catastrophic predictions, physiological arousal, avoidance routines, excessive reassurance, and the restriction of everyday functioning. Assessment needs to establish the feared situations, their realistic danger, the function of avoidance, developmental factors, and the role of caregiver responses. Exposure-based cognitive behavioral interventions typically combine an understandable treatment model with supported practice in feared situations, cognitive and behavioral skills, and attention to relapse or renewed avoidance.
The James (2020) included 87 randomized trials involving 5,964 young people with anxiety disorders. For recovery from an anxiety diagnosis, the review reported approximately 49.4% in cognitive behavioral therapy conditions versus 17.8% among participants assigned to waiting lists, corresponding to an odds ratio of 5.45 with a 95% confidence interval from 3.90 to 7.60. This contrast establishes meaningful benefit over waiting, while comparison with treatment as usual or another active intervention supports more qualified conclusions. Trial populations, follow-up windows, and outcome ascertainment differ, and reporting of adverse events remains incomplete in parts of the literature.
The multicenter Walkup (2008) randomized 488 participants aged seven to seventeen to cognitive behavioral therapy, sertraline, their combination, or placebo. At twelve weeks, the reported clinical response rates were approximately 80.7% for combination care, 59.7% for cognitive behavioral therapy, 54.9% for sertraline, and 23.7% for placebo. The significance of this study is its direct comparison across intervention arrangements within a clearly described population and period. Its results cannot serve as an individualized prescription; selection among psychological, combined, and other treatments depends on assessment, preferences, safety, access, and current clinical guidance.
The Walter (2020) provides a professionally developed framework for assessment and evidence-based treatment selection. Across youth anxiety trials, researchers continue to ask how developmental adaptation, caregiver involvement, session intensity, social anxiety presentation, comorbidity, and service setting moderate outcome. Modern studies should also report whether fear reduction produces sustained school and social participation. An intervention can change symptom reporting before the young person independently approaches previously avoided activities, making functional follow-up an important component of the scientific endpoint.
Depression, Interpersonal Psychotherapy, and Behavioral Activation
Depression during adolescence can involve persistent sadness or irritability, diminished interest, disrupted sleep and energy, hopelessness, cognitive difficulties, reduced school participation, and substantial impairment in relationships. The treatment formulation examines severity, duration, comorbid anxiety, family stress, peer relationships, safety concerns, and the ways low activity and adverse expectations may maintain symptoms. Cognitive behavioral methods address behavioral withdrawal and cognitive patterns, while interpersonal psychotherapy for adolescents focuses on depressive symptoms in connection with grief, role transitions, disputes, and interpersonal functioning.
A randomized trial by Mufson (1999) compared interpersonal psychotherapy for depressed adolescents with a clinical-monitoring control condition, providing an early controlled test of a developmentally adapted interpersonal approach. Later trials extended comparative evaluation across psychological and pharmacological interventions. In the Treatment for Adolescents With Depression Study (TADS) Team. (2004). Fluoxetine (2004), adolescents were randomized to cognitive behavioral therapy, fluoxetine, their combination, or placebo. Interpretation depends on the outcome used, treatment phase, and accompanying safety measurements, rather than a single declaration that one intervention dominates across all circumstances.
The Brent (2008) studied adolescents whose depression had not responded adequately to an initial selective serotonin reuptake inhibitor. Adding cognitive behavioral therapy to a medication switch produced a higher reported response rate than medication switching alone, approximately 54.8% compared with 40.5%. The research illustrates how psychotherapy can be assessed as an additional component within a treatment sequence, particularly for more difficult clinical presentations. It does not establish the effectiveness of CBT alone in this specific comparison, and medication decisions remain medical decisions.
The National Institute for Health and Care Excellence. (2019). Depression in children and young people: Identification and management (NICE Guideline NG134). https://www.nice.org.uk/guidance/ng134/chapter/Recommendations (2019) organizes treatment by age, severity, patient and family preferences, and clinical context. Depression research faces persistent questions about nonspecific improvement, low or variable effects in some comparisons, long-term recurrence, and how changes in interpersonal functioning and daily activity contribute to clinical recovery. The field benefits from outcome sets that extend beyond symptom scales to participation, safety, treatment acceptability, and sustained functioning, with transparent reporting of adverse events and clinical deterioration.
Recurrent Self-Harm, Suicidality, and Emotion Dysregulation
Self-harm and suicide-related presentations are clinical priorities because the consequences of incomplete assessment or fragmented treatment can be severe. Young people may self-harm for different reasons, including attempts to regulate overwhelming emotion, communicate distress, respond to interpersonal conflict, or manage dissociation. The presence of self-harm does not by itself reveal suicidal intent, but assessment must address immediate and longer-term safety, the function of the behavior, associated psychiatric symptoms, environmental risks, and access to supportive care. Research separates deliberate self-harm outcomes, suicidal ideation, suicide attempts, overall distress, and recurrence, as these endpoints are not interchangeable.
Dialectical behavior therapy for adolescents adapts behavioral and cognitive methods to address emotion regulation, distress tolerance, interpersonal effectiveness, and patterns associated with recurrent self-harm. In a randomized trial, Mehlum (2014) evaluated DBT for adolescents with repeated suicidal and self-harming behavior. Rossouw (2012) examined mentalization-based treatment for adolescent self-harm in another randomized controlled study. These trials contribute evidence for interventions designed for high-risk young people, but conclusions about individual components and the durability of effects depend on study design, sample, endpoint, and follow-up.
The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) emphasizes a comprehensive psychosocial assessment, collaborative planning, and appropriate continuity of care. It advises against applying risk scales or risk categories to predict future suicide or mechanically determine who receives treatment. Its recommendation to consider DBT adapted for adolescents in specified circumstances is narrower than a universal directive to use one therapy for all young people who self-harm. Services also require systems for timely escalation, safeguarding, referral, and coordination with emergency and specialist care as indicated.
Ethically robust studies record adverse outcomes and participation burdens, including how researchers respond to disclosure of acute risk. In ordinary practice, reliable safety response is part of the organizational intervention even when psychotherapy addresses a longer-term maintaining process. The evidence base must be interpreted separately for suicide attempts and nonsuicidal self-injury, for acute crisis stabilization and longer-term psychotherapy, and for youth who can access a full structured program versus those with interrupted care. Effective treatments are embedded in safe, responsive service pathways.
Externalizing Problems, Parent Training, and Family Systems
Externalizing presentations include oppositional behavior, aggression, persistent conflict, and disruptions in school or family participation. Explanations may involve reinforcement contingencies, emotion regulation, developmental vulnerabilities, trauma exposure, family stress, peer contexts, and institutional responses. A useful formulation examines actual behavioral sequences and the circumstances in which difficulties arise. Treating an externalizing label as a complete explanation overlooks the child's abilities, relationships, learning profile, and the function of problematic behavior. Assessment should also identify safety risks and conditions that can be modified in the environment.
Parent-management training and other behavioral family interventions have a substantial empirical tradition. Eyberg (2008) differentiates treatments with varying levels of support for disruptive behavior. The interventions generally focus on predictable routines, positive reinforcement, effective instructions, caregiver responsiveness, and modifying cycles of coercive interaction. The target is not simply a child's compliance but reduction of impairing behavior and improvement in adaptive relationships and functioning. Outcome measurement should include the situation and informant because observed change at home may not automatically generalize to school.
For more severe patterns involving justice systems, substance use, peers, and family instability, multisystemic treatment models seek to alter interacting influences across settings. An early study by Henggeler (1999) examined multisystemic treatment in substance-abusing and dependent juvenile offenders, including questions of fidelity and transportability. Such highly coordinated interventions differ materially from brief individual counseling. Their conclusions must remain tied to enrollment characteristics, available comparison conditions, program intensity, and the institutional setting.
Parent-focused methods should be evaluated for acceptability and fairness, especially when caregivers face material deprivation, discrimination, disability-related needs, or limited access to services. A treatment that relies on sustained parental availability imposes different burdens on households with unstable work or caregiving arrangements. Family violence, exploitation, or other safety concerns may require protective pathways that take precedence over routine family engagement. A comprehensive trial report includes implementation context, feasibility, and adverse experiences, not only a summary behavioral symptom score.
Eating Disorders and Family-Based Psychological Treatment
Eating disorders in adolescence present a distinctive interface between psychiatric symptoms, physical health, developmental autonomy, and family functioning. Restrictive eating, fear of weight gain, compulsive exercise, binge eating, and other behaviors may interact with malnutrition and significant medical risk. Psychotherapy must therefore be situated within interdisciplinary assessment and monitoring rather than treated as an independent substitute for needed medical care. Age, diagnosis, physical stability, family circumstances, and patient preference influence the form of psychological intervention.
Family-based treatment for adolescent anorexia nervosa involves a structured role for caregivers in supporting nutritional rehabilitation and gradually restoring age-appropriate autonomy. The randomized comparison by Lock (2010) contrasted family-based treatment with adolescent-focused individual therapy. Its follow-up findings favoring family-based treatment on full remission supplied condition-specific evidence for a family-centered approach, while also illustrating the importance of clearly defined remission criteria and follow-up. Different eating disorders, medical states, and family circumstances require separate evidence.
Research outcomes in this field include psychological symptoms, eating-disorder behavior, nutritional and medical stabilization, family functioning, and adverse events. Physical recovery markers have clinical importance but do not by themselves establish recovery of self-image or social functioning. Trials must specify how medical care and psychological interventions were coordinated and how dropout was handled. The young person's experience of treatment matters, particularly when symptoms and medical risk create tension between autonomy and necessary protection.
A broader lesson for child and adolescent psychotherapy is that the effective unit of care may extend beyond the therapist–patient dyad. Some conditions require families, clinicians, dietetic or medical professionals, and schools to work from an integrated plan. The scientific challenge is to identify which elements are causally consequential, which are necessary supportive conditions, and which are contextual responses to severity. Comparing intervention packages without describing their associated services can obscure important differences in patient outcomes.
Complex Presentations, Comorbidity, and Treatment Resistance
Clinical populations often differ from the narrowly defined groups enrolled in early efficacy trials. Anxiety may coexist with depression, neurodevelopmental differences, chronic illness, traumatic stress, substance use, behavioral difficulties, or family adversity. These combinations can modify the treatment target, pace, contact format, and measures of progress. The existence of several diagnoses does not automatically imply that several complete treatment manuals should be delivered in succession. A collaborative formulation instead prioritizes impairment, safety, and plausible maintaining processes, then examines whether the sequence of interventions is producing benefit.
The Brent (2008) illustrates why treatment history matters: adolescents with depression persisting after an initial medication course represented a different clinical population from first-presentation samples. Other complex presentations may involve previous unsuccessful psychotherapy, interrupted contact, inconsistent caregiver support, or difficulties in access. These are not equivalent forms of treatment resistance, and the term should be operationally defined before being used as a predictor. Documenting delivered treatment dose and fidelity is necessary before concluding that a young person failed to respond to a tested intervention.
Clinical adaptation may involve concrete communication, sensory accessibility, additional time, reduced organizational complexity, coordination with education services, and alternative outcome measures. Those modifications should be documented rather than treated as invisible deviations from a manual. Research involving neurodivergent young people and those with intellectual or communication disabilities needs measures that capture accessible participation and meaningful improvement. Investigators must avoid assuming that all observed differences in social behavior are pathological targets of treatment.
An effective treatment system supports reassessment when a chosen approach has produced little benefit or is causing distress. Reassessment may identify an inaccurate target, a new safety concern, unrecognized environmental barriers, inadequate treatment delivery, or a need for a different intervention. The scientific question is whether explicit adaptive decision rules outperform fixed treatment courses for a given presentation and context. This agenda requires adequately powered and transparently reported sequential studies, longitudinal outcome measurement, and attention to family and youth preferences.
Evidence Synthesis Across Diagnostic Categories
The broadest youth psychotherapy meta-analyses support the conclusion that psychological treatment can produce clinically meaningful average gains, with pronounced heterogeneity. Weisz (2017) reported a mean effect around 0.46 across 447 randomized studies, and their analyses highlighted differences between anxiety, depression, and multi-problem interventions. Stronger average outcomes for some anxiety treatment packages should not lead to a judgment that all depressive or complex interventions are ineffective. It signals different trial populations, treatment targets, control conditions, reporting systems, and possibly mechanisms.
Meta-analysis pools contrasts, not abstract therapeutic qualities. If two trials compare distinct forms of CBT against different control groups, their effect estimates may answer different questions. Outcome informants also vary: a caregiver may report behavioral improvement that a teacher cannot observe, or a young person may report reduced internal distress before a parent notices any difference. This variability is a methodological reason to preserve informant identity and context in synthesis. Collapsing all reporters and follow-up windows without exploration can conceal clinically important variation.
Disorder-specific guidelines and Cochrane reviews provide useful triangulation because their eligibility criteria and evidentiary judgments are explicit. The James (2020), for instance, distinguishes confidence in CBT benefits against waiting lists from confidence in other comparisons. Likewise National Institute for Health and Care Excellence. (2019). Depression in children and young people: Identification and management (NICE Guideline NG134). https://www.nice.org.uk/guidance/ng134/chapter/Recommendations (2019), National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE Guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018), and National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) applies condition-specific considerations to distinct clinical pathways. A synthesis should preserve these distinctions even while identifying shared developmental principles.
Across the field, conclusions with the greatest practical relevance concern a joint set of questions: Which intervention package improves which outcome in which group of young people, relative to what alternative, under what service conditions, and for how long? This framework prevents extrapolation of an impressive result from one clinical domain into an unsupported universal formula for youth therapy. It also reveals where evidence remains weak: adverse-event monitoring, youth-reported experience, marginalized populations, long-term functioning, and comparisons between credible active treatments.
Digital Psychotherapy, Telehealth, and Hybrid Care
Digital care encompasses several distinct interventions: video-based sessions with a qualified therapist, online modules supported by therapist contact, parent-assisted self-help, mobile tools for tracking and homework, and automated conversational systems. These formats differ in clinical intensity, interpersonal contact, privacy arrangements, and the ability to respond to deterioration. The label digital psychotherapy is scientifically useful only when the actual intervention, degree of professional oversight, and population are specified. A video session that reproduces a standard therapeutic appointment is not equivalent to an unguided app or to an automated response system.
Digital interventions can reduce some travel and scheduling barriers, yet access to stable internet, private space, appropriate devices, and supportive adults varies substantially. For a child living in a crowded household, remote sessions may provide less privacy than an outpatient visit. An adolescent's shared device may create opportunities for unintended disclosure. In videotherapy, clinicians must also consider how to verify a safe location, obtain developmentally appropriate consent, and coordinate an appropriate response to an acute safety concern. These requirements are part of the intervention's clinical and ethical design.
In a March (2025), March and colleagues evaluated integration of video therapist guidance into stepped-care internet-delivered CBT for youth anxiety. The study did not establish the prespecified noninferiority conclusion and found advantages for guidance on some outcomes. This result demonstrates that equivalence of digital contact arrangements cannot be assumed merely because both contain CBT content. Guidance, support intensity, adherence, and delivery infrastructure need to be represented in efficacy models.
A Sørensen (2026) examined internet-based CBT for anxiety in children and adolescents and considered the influence of age and support. The findings suggest potential benefit but also a comparatively small and heterogeneous evidence base, with uncertainty introduced by the types of controls studied. In a different population, Di Pierdomenico (2026) synthesized universal digital mental-health interventions across 57 studies involving 43,973 young people and found mostly small effects and low-certainty pooled evidence. Because universal prevention for nonclinical populations differs from indicated psychotherapy, these results should be used to compare service models and population reach rather than to infer equivalence of treatment efficacy.
Artificially Mediated Support and Psychological Accountability
Artificially mediated mental-health support extends beyond ordinary telehealth. Systems may generate psychoeducation, guide structured exercises, summarize client-reported data, recommend resources, or simulate conversational support. Research questions concern accuracy, emotional accessibility, the effect on human help-seeking, privacy, harmful advice, and the degree of clinical oversight. Young users may assign interpersonal meaning to a responsive system. Such engagement is relevant to psychology even when a tool is evaluated primarily as software. Claims about clinical competence, therapeutic relationship, or safety require direct evidence from the system and population being studied.
The distinction between supportive technology and clinical treatment must be made operational. If an intervention claims to deliver CBT, investigators should document which components are implemented, whether content matches a defined protocol, whether symptoms and risk are assessed, and how departures from a safe interaction are handled. Automated adaptation can introduce inconsistency: two young people with similar clinical presentations might receive materially different suggestions. Research on reproducibility must therefore preserve versions, prompts or decision rules, escalation pathways, and the exact scope of allowed behavior without exposing sensitive personal information.
For minors, privacy protection and safeguarding are especially consequential. Data can include disclosures about family relationships, trauma, identity, self-harm, or abuse. A user may reasonably misunderstand what an automated system can remember, share, or do in a crisis. Evaluation should test comprehension of the system's capabilities, youth and caregiver consent arrangements, the fidelity of emergency instructions, and the consequences of erroneous reassurance or escalation. Clinical governance should specify responsibility for monitoring, correction, and referral before a system is introduced as a mental-health service.
This research area is relevant to the historical transition toward an Artificial Era, in which human psychological practices increasingly incorporate nonbiological information-processing systems. The philosophical vocabulary of Artificial Sapiens and human–Artificial relations describes a research horizon, while claims about particular tools belong to empirical study. A conversational simulation of rapport is an observable interactional phenomenon; its clinical efficacy, effects on dependency, and developmental consequences remain questions for preregistered trials, comparative observation, and long-term safety research. A responsible science examines both the human experience of the relation and the technical behavior of the system.
Cultural Context, Language, and Structural Conditions
Cultural context informs the meaning of psychological symptoms, the language available for emotional description, expectations of family involvement, understandings of privacy, and preferred forms of help. Developmental tasks are not expressed identically in every social setting. The scientist or clinician must therefore ask whether a measure developed in one population captures the intended construct in another, whether translation preserves meaning, and whether a treatment's assumptions fit the young person's context. Cultural responsiveness is a continuing task of formulation and evaluation rather than a fixed attribute that can be assigned to an intervention by name.
Structural conditions affect both distress and treatment access. Poverty, unstable housing, discrimination, exposure to violence, migration and displacement, limited health insurance, transport costs, and uneven geographic distribution of specialist clinicians can influence who is referred, who can attend, and whose outcomes are recorded. These factors may also modify treatment response by changing opportunities to carry out homework or sustain improvements. A clinical trial conducted with highly supported families can estimate treatment efficacy accurately within its population while remaining less informative about families facing substantial barriers.
Translation and adaptation research can examine changes in language, imagery, examples, family roles, and service delivery. To evaluate adaptation scientifically, researchers should state what was changed, explain the rationale, and test fidelity and outcomes. An adaptation that improves acceptability may strengthen engagement without independently proving superior symptom reduction; conversely, an intervention can be effective on one measure while being experienced as culturally alienating. Both observations matter to implementation science. Local participants should contribute to the definition of meaningful outcomes, especially when standardized measures were developed elsewhere.
Equity also involves representation within research designs. Youth experiencing disability, complex family structures, homelessness, institutional care, or ethnic and linguistic marginalization may be excluded by eligibility criteria that simplify the trial. Those exclusions limit generalizability and may weaken knowledge about the very service settings with the greatest needs. A mature evidence base reports who was included, who was excluded, why families declined participation, and whether the intervention was accessible across different environments. Interpretation must avoid treating the circumstances of a convenience sample as universal developmental psychology.
Community Services, Global Mental Health, and Implementation
Psychological therapies operate within service systems that determine referral, assessment, treatment intensity, supervision, crisis response, and follow-up. A treatment manual demonstrated to be effective in a specialized clinic may require training, organizational capacity, and protected clinical time that are difficult to reproduce in routine services. Implementation research studies the transition from efficacy to sustainable delivery: clinician competence, workload, fidelity, acceptability, costs, organizational support, and outcomes of the young people actually treated.
The World Health Organization. (2024). Mental health of children and young people: Service guidance. https://www.who.int/publications/i/item/9789240100374 (2024) emphasizes service organization, access, and approaches spanning community contexts. International research must take seriously the diversity of mental-health infrastructures, including differences in the availability of licensed specialists, primary care, schools, community health workers, and safeguarding services. An intervention demonstrated in a high-income specialist setting cannot simply be assumed feasible in regions with different resources or legal protections. Task-sharing and stepped-care models require specific study of training, supervision, referral, safety, and achieved outcomes.
The Weisz (2012) helps connect treatment efficacy to actual service delivery by testing flexible modular approaches in clinical settings addressing several common problems. It raises a broader implementation question: whether clinicians can maintain evidence-informed treatment operations while adapting to heterogeneity and interruptions. Training alone is rarely an adequate implementation measure. Researchers also need observation of actual practices, clinical outcomes, patient experience, and whether the program remains functional after initial research support ends.
Service design should preserve continuity across childhood and adolescent transitions. Young people may move among school support, primary care, specialist mental-health services, crisis services, and adult systems. Referral failures or incompatible documentation can interrupt treatment precisely when needs intensify. Longitudinal service studies can assess timing of access, dropout between stages, readmission, referral completion, and functional outcomes. The ethical objective of providing accessible care is supported by evidence when the service system can show what care was delivered, to whom, with what outcomes and harms.
Preventive Programs and the Boundary with Psychotherapy
Many programs delivered to children and adolescents aim to improve psychological well-being before a clinical disorder emerges. Universal social-emotional learning, mental-health literacy, resilience curricula, and school-wide coping initiatives may influence mental-health indicators, but their eligibility criteria, intensity, and target outcomes differ from treatment for diagnosed clinical problems. Selective prevention targets elevated risk groups; indicated prevention addresses subclinical symptoms; psychotherapy generally involves individualized clinical assessment and a treatment plan. These boundaries should be reported explicitly because a small universal preventive effect and a larger indicated clinical-treatment effect answer different policy questions.
A Tsujimoto (2026) synthesized 59 studies of universal school-based mental-health programs including 83,092 students across 22 countries. It reported small mean reductions in internalizing and externalizing symptoms, with variation by program and sample characteristics. This evidence supports careful evaluation of universal provision while illustrating why widespread reach does not imply a large effect for each participant. It also demonstrates the importance of school-level conditions and the distinction between prevention effectiveness and clinical psychotherapy outcomes.
Likewise, Di Pierdomenico (2026) assessed universal digital interventions and found that pooled effects varied across emotional, behavioral, social, and cognitive outcomes. Hybrid delivery showed more consistent findings in some analyses, while many comparisons had low certainty. Such interventions may constitute useful parts of a population mental-health ecosystem, but they should be evaluated alongside the cost of implementation, accessibility for marginalized groups, and pathways to more intensive care. Screening and preventive education have limited value when indicated follow-up treatment is unavailable.
Scientific synthesis benefits from a common reporting framework across prevention and treatment: clearly define intended population, intervention components, duration, comparison, outcome, time point, implementation conditions, and harms. The effect of a school-wide curriculum on average mood cannot be directly interpreted as the probability that a severely depressed adolescent will recover from psychotherapy. Accurate classification protects both scientific conclusions and rational service planning.
Measurement, Psychometrics, and Statistical Inference
Measurement in child and adolescent psychotherapy faces problems of developmental equivalence, informant disagreement, repeated assessment, and the sometimes indirect relationship between symptoms and function. Instruments should be evaluated for reliability, sensitivity to change, construct validity, and appropriateness for age, language, disability, and cultural context. An item about workplace functioning, for example, may be inappropriate for a younger school-age child; a question requiring abstract introspection may have different meaning across ages. Research involving changes in a scale across development should examine whether the same underlying attribute is being measured.
The De Los Reyes (2005) model of informant discrepancies remains central because disagreement is not necessarily an error to be eliminated. A young person reports internal experience, a caregiver observes household interactions, and a teacher observes peer and classroom functioning. Variation across contexts can be a feature of the construct. When clinical outcomes use one reporter and intervention participation changes that reporter's expectations, apparent benefit may reflect an interaction of actual change and changed perception. Independent observation and convergent measures can reduce, though not eliminate, this ambiguity.
Randomized trials require transparent allocation, appropriate control groups, prespecified outcomes, and attention to missingness. Waiting lists are often practical but do not control for all expectancy and contact differences. Treatment as usual may vary across sites and change over time. Effect sizes require confidence intervals and information about clinically meaningful thresholds, while subgroup analyses should be interpreted in relation to statistical power and multiplicity. Blinding the young person or therapist to psychological intervention is often impractical, making masked independent outcome assessment valuable when available.
Complex designs may be needed to model children within families, therapists, schools, and service organizations. Cluster randomization can reduce contamination but requires attention to intracluster correlation. Repeated measures can estimate trajectories but risk bias if deterioration causes selective dropout. Mediation analyses need a temporal sequence and assumptions about confounding; they do not automatically reveal causal psychological mechanisms. Researchers should prospectively document protocol changes, intervention versions, therapist training, adherence, and adverse events so that independent replication has a meaningful target.
Adverse Outcomes, Safety Measurement, and Clinical Governance
The evaluation of youth psychotherapy must include outcomes that clinicians and families hope to prevent. Clinical deterioration, emergent suicidal thoughts, increased family conflict, worsening school participation, disclosure-related harm, breaches of confidentiality, treatment-induced distress, and delayed access to more appropriate care are potential concerns that vary by intervention and population. Some distress is expected during therapeutic work, particularly during exposure or trauma processing, so harm cannot be identified solely by whether a session felt uncomfortable. Research needs prespecified clinically meaningful definitions, repeated monitoring, and documented responses.
Adverse-event evidence in psychological treatment is less consistently gathered than symptom outcomes. The James (2020) notes limitations affecting certainty about some outcomes. When trials fail to report harms, this absence is not evidence that harms never occurred. A robust protocol identifies who can report an event, how severity and causality are assessed, how acute risk is handled, and how withdrawal from treatment is documented. Published results should state denominators and distinguish adverse events from expected temporary emotional activation.
Clinical governance includes supervision, scope of professional competence, referral pathways, safeguarded recordkeeping, and clear roles during emergencies. Professionals treating minors require knowledge of developmental assessment and local legal rules concerning consent and safeguarding. Programs delivered through schools or digital platforms require the same clarity about clinical responsibility. A service should know how to respond when the child is unreachable, a caregiver is implicated in a reported harm, or ordinary sessions cannot provide the intensity of assessment or care needed.
The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) explicitly discourage mechanical stratification of young people into predictive risk categories and support individualized assessment and care planning. This approach illustrates an important relationship between evidence and safety: an instrument may describe symptoms or support conversation without accurately determining future individual suicide outcomes. Clinical decisions must therefore incorporate comprehensive assessment, protective systems, and ongoing review, with research measuring whether these organizational responses actually improve safety and continuity.
Therapeutic Evidence in 2025–2026
Recent research adds detail to digital delivery, prevention, and synthesis across treatment modalities. A March (2025) showed that specific assumptions about equivalent modes of internet-delivered youth anxiety treatment need direct testing. A Sørensen (2026) provided a synthesis focused on age and treatment support, while identifying limited certainty in the developing evidence base. These findings reinforce the importance of specifying how contact is delivered, what therapeutic functions are performed, and which families can participate.
A Sánchez-Álvarez (2026) examined aggregated evidence on psychological and digital interventions across adolescents and young adults. It estimated a modest overall positive effect on mental-health and well-being outcomes while documenting the heterogeneity of the included evidence. Its population breadth and inclusion of preventive and positive-well-being interventions make it informative about the landscape of youth supports, but its pooled estimate is not an effect size for clinical psychotherapy in childhood. Appropriate conclusions follow the exact inclusion criteria and endpoints.
The Di Pierdomenico (2026) and the Tsujimoto (2026) further illustrate why claims about scale and effectiveness require separate evidentiary treatment. Broad-reach interventions may provide modest average benefits across many students; specialist psychotherapy trials address more selected clinical needs. The research challenge is to determine efficient pathways linking early support, assessment, stepped interventions, and specialist care while preventing both overtreatment and delayed treatment.
Taken together, newer studies make several priorities visible: transparent active comparators, intervention-component reporting, longitudinal outcomes, measurement of participation and harms, and inclusion of families and communities currently understudied. Contemporary work also increasingly examines the effects of digital and hybrid delivery on therapeutic contact and treatment access. Advances in synthesis and technology create new empirical questions rather than dissolving the need for independent, developmentally informed clinical evidence.
Individual Differences, Moderation, and Treatment Matching
A central ambition of child and adolescent psychotherapy science is to explain why different young people benefit to different degrees from the same treatment. Potential moderators include age, problem severity, comorbidity, developmental and language capacities, trauma exposure, family resources, baseline avoidance, treatment preference, cultural setting, and access barriers. A moderator is scientifically informative when it predicts a differential response to treatment assignment, not simply when it correlates with overall prognosis. A characteristic associated with improvement in every condition may be prognostic without demonstrating that a particular therapy is preferable.
The strongest treatment-matching claims require direct comparisons between credible alternatives with adequate sample size for interaction tests. For example, a trial could examine whether caregiver-supported versus youth-only CBT produces different benefits according to child age or family accommodation, while measuring the same clinical outcomes across arms. A within-treatment association between parental participation and outcome cannot establish that parents caused the improvement, because more available and less distressed families may both attend more sessions and have better prognosis. Similar selection problems affect conclusions about self-guided digital treatment versus therapist-guided care.
Many personalization studies are underpowered for reliable subgroup inference, and post hoc analyses can magnify noise. Predictor selection should reflect theory and be evaluated out of sample. Researchers need transparent treatment definitions, prespecified interaction analyses, correction for multiplicity where relevant, and replication in independent settings. Prediction models should be calibrated for the actual population and compared against simpler clinical baselines. A statistically significant subgroup effect is insufficient evidence for changing service policy if the subgroup is small, unstable, or defined by difficult-to-measure characteristics.
The practical goal is an adaptive service in which reassessment is routine and treatment choices are revisited when progress stalls. That goal requires monitoring clinical response, engagement, adverse events, and changes in circumstances. It can be studied through sequential randomized designs, pragmatic comparisons, and clinically interpretable decision rules. Personalization becomes a scientific achievement when it identifies reproducible circumstances under which a particular intervention sequence improves meaningful outcomes.
Longitudinal Development, Relapse, and Sustainability
Psychological therapy takes place over a short part of a much longer developmental course. Symptoms may emerge, remit, return, or change form as social roles, schooling, family responsibilities, and peer environments evolve. A treatment study reporting postintervention benefit establishes change at a specified point. Assessing whether this change persists requires follow-up measured against the same clinical and functional domains, with attention to later care, life events, and selective attrition. A young person who seeks additional treatment after the original trial should not automatically be counted as if the first intervention remained the sole causal influence.
Durability has several meanings. Maintenance of symptom reduction differs from increased capacity to manage future stress, improved school engagement, and the recovery of relationships. Relapse may be defined diagnostically, psychometrically, or by return of functional impairment, and these definitions should be made explicit. Some youth may retain skills but confront new challenges requiring additional support. A developmental outcome may also become more stringent with age: independent participation expected from an older adolescent differs from the level expected of a younger child.
Longitudinal designs should measure the context in which treatment effects are sustained. Caregiver behavior, school transition, peer support, the stability of housing, recurrence of adversity, and changes in health can influence outcomes. Studying these factors allows researchers to ask whether therapeutic skill acquisition predicts later adaptation and whether service continuity modifies that relationship. Observational follow-up can reveal trajectories, but causal inference about maintenance programs or booster sessions requires appropriate comparisons.
Sustainable benefit also includes the ability of a service to remain available. Highly supported research programs may operate differently after special funding ends. Evaluation across years should consider clinician turnover, training, adaptations, referral patterns, and youth access. Sustained clinical recovery and sustained organizational implementation are two different but interacting scientific questions. Both belong in the long-term evaluation of youth psychotherapy.
Comparative Scientific Discussion
The evidence most strongly supports specific conclusions for specific interventions. Cognitive behavioral approaches for youth anxiety have substantial randomized evidence, especially against waiting-list comparisons. Particular adolescent depression therapies, trauma-focused interventions, behaviorally oriented parenting programs, DBT adaptations for recurrent self-harm, and family-based approaches for anorexia nervosa each possess identifiable controlled trial traditions. Their studies differ in population, comparison, intensity, safety requirements, and outcome definition. Scientific comparison preserves these differences instead of ranking all interventions along one universal scale.
Several broad explanations remain plausible but underdetermined. A therapy package may benefit a young person through expected learning mechanisms, therapeutic relationship, participation in valued activities, caregiver support, or other co-occurring processes. Trials of packages generally demonstrate overall effects, while studies that disentangle active components require more selective intervention contrasts and appropriately timed process measurement. The need for stronger causal mechanism evidence is compatible with existing evidence that some packages help. It identifies what further research must explain about their operation.
A second major issue is ecological validity. Specialist clinical trials may provide intensive supervision, restricted eligibility, standardized training, and active follow-up. These features improve treatment fidelity and internal validity while sometimes limiting transportability to routine services. Pragmatic trials and observational service data address complementary questions. Their results are most useful when documented treatment components, case mix, provider characteristics, outcome measures, and missing data permit interpretation. Weisz (2012) demonstrates the value of studying treatment designs in ordinary clinical settings.
A third issue is epistemic representation. Children and adolescents experience symptoms and environments that adults only partly observe. A parent, therapist, and teacher may each correctly report a different aspect of functioning. Measures informed by youth priorities can improve the relevance of treatment evaluation, though self-report remains subject to expectancy and context. De Los Reyes (2005) provide a scientific basis for interpreting reporter discrepancies rather than declaring one observer the sole source of truth. A credible evidence synthesis seeks convergence without erasing situational specificity.
An Integrated Framework for Research and Practice
An integrated scientific framework begins with a precisely defined treatment question: a specified age and clinical population, a measurable difficulty, a clinically credible intervention, a comparison, and outcomes that matter to the young person. The next layer is developmental and contextual formulation: capacities, preferences, family relationships, school environment, environmental risks, and access. Intervention design then identifies the proposed active operations, their delivery format, and the conditions under which they can be implemented safely. Evaluation connects those elements through repeated outcome measurement, treatment fidelity, adverse-event surveillance, and follow-up.
The framework can be described as six linked functions. Assessment establishes the problem and baseline. Collaborative formulation identifies hypotheses and priorities. Intervention implements defined psychological operations. Coordination supports developmentally appropriate participation by caregivers, peers, schools, and services. Measurement estimates beneficial and adverse changes. Reassessment determines whether to maintain, adapt, intensify, or change care. These functions may occur repeatedly within a treatment episode, and their scientific merit rests on observable procedures and testable relationships.
An evidence-based intervention can be delivered poorly; a responsive clinician can deliver an intervention whose specific efficacy remains uncertain; an intervention with strong trial evidence can be inaccessible or unwanted. For this reason, intervention efficacy, implementation fidelity, therapeutic engagement, cultural appropriateness, and service equity should be measured as separate and interacting constructs. Each can contribute to an observed outcome, but their relative causal roles require research. This integrated approach treats scientific evidence as a guide to explainable action rather than as a substitute for developmental and clinical assessment.
The framework also distinguishes clinical benefit from broader social and technological transformation. Digital tools can alter access, process measurement, and patterns of emotional disclosure. The increasing participation of Artificial systems in psychologically meaningful settings demands clear definitions of professional responsibility and empirical standards for claims of efficacy and safety. A psychotherapy service remains accountable for its consequences across the full treatment pathway, irrespective of whether a particular interaction is conducted in person, remotely, or with algorithmic assistance.
Unresolved Problems and Research Priorities
A first priority is stronger head-to-head evidence among credible active interventions. Many published effect estimates are largest or clearest against minimal-contact conditions. More rigorous comparisons are needed to determine when a particular therapy adds value over existing practice, for which populations, and at what burden. These designs should capture resource use and adverse events alongside symptoms. Pragmatic comparative trials could also evaluate treatment sequences and the value of modular adaptation under ordinary service conditions.
A second priority concerns mechanisms. Repeated assessment can establish whether proposed process changes precede clinical improvements, while randomized manipulation of components can test causal claims. Researchers must account for feedback between outcomes and alliance, between avoidance and family accommodation, and between mood and social participation. Relevant timescales differ: learning may occur in a single exposure session, whereas family routines may shift over weeks and recovery of social functioning may take months. Mechanistic conclusions should be tied to the level and timing actually measured.
A third priority is representation and generalizability. Studies should include younger children, marginalized communities, young people with disabilities and complex comorbidity, and families whose access barriers are typically treated as exclusion criteria. Measures require appropriate language adaptation, validated developmental interpretation, and a clear role for youth-reported outcomes. Clinical and implementation studies in low- and middle-income contexts are especially important for understanding which intervention functions are transferable and which depend on particular service infrastructures.
A fourth priority is ethical and technical accountability in digital and Artificial interventions. Necessary questions include whether automated guidance maintains protocol fidelity, whether young people understand confidentiality limits, whether biased outputs alter access or safety, and whether human escalation functions in practice. Evaluation should preserve software versions and predefined intervention behavior so that an effect estimate refers to a reproducible system. Longitudinal follow-up can investigate how the child's understanding of automated support and human relationships changes with sustained use.
A fifth priority is the explicit study of nonresponse and adverse outcomes. Trials should report deterioration, clinically significant safety events, withdrawals, and reasons for discontinuation, along with policies used to address them. Follow-up should measure functioning across home, school, and peer contexts. Research that includes both intended and unintended effects provides a stronger basis for clinical choice and organizational responsibility than an efficacy estimate alone.
Conclusion
Child and adolescent counseling and psychotherapy constitute a developmentally situated field of psychological intervention in which individual learning, family interaction, therapeutic relationships, school participation, clinical safety, and institutional access jointly shape treatment outcomes. The empirical literature supports the effectiveness of several defined interventions for specified youth problems. Controlled trials and meta-analyses are especially informative for CBT-based anxiety treatment and provide important condition-specific findings for depression, trauma, recurrent self-harm, disruptive behavior, and eating disorders. The quality and scope of this evidence vary by comparator, clinical presentation, age, measurement system, follow-up, and treatment setting.
A coherent scientific interpretation requires attention to the exact intervention and outcome being evaluated. Symptom reduction, functional recovery, durable improvement, acceptability, and safety describe related but distinct dimensions of therapeutic benefit. Multi-informant observation and developmental assessment are indispensable because the young person's distress and participation span contexts that no single observer fully captures. Caregiver participation and school coordination can support treatment transfer, yet their roles must be defined and studied in relation to family conditions and adolescent autonomy.
The historical development of the field has moved from early relational and developmental formulations toward increasingly explicit experimental comparison, evidence synthesis, modular intervention, and implementation research. This development establishes a foundation for investigating mechanisms while leaving significant causal questions open. The next stage of research requires stronger active comparisons, prospective measurement of change processes, improved representation of diverse youth populations, systematic adverse-event reporting, and long-term follow-up of both psychological functioning and service access.
Within the Artificial Era, digital and Artificial systems become new contexts for support, communication, measurement, and possible treatment delivery. Their contribution is a matter for clinical testing, ethical governance, and developmental research. The enduring task of child and adolescent psychotherapy is to connect scientifically supported psychological interventions with the changing capacities, relationships, needs, and environments of young people, and to evaluate that connection through transparent, reproducible evidence.
References
- Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., Birmaher, B., Ryan, N., Kennard, B., Hughes, C., DeBar, L., McCracken, J., Strober, M., Suddath, R., Spirito, A.,. Zelazny, J. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA, 299(8), 901–913. https://doi.org/10.1001/jama.299.8.901
- Chorpita, B. F., & Daleiden, E. L. (2009). Mapping evidence-based treatments for children and adolescents: Application of the distillation and matching model to 615 treatments from 322 randomized trials. Journal of Consulting and Clinical Psychology, 77(3), 566–579. https://doi.org/10.1037/a0014565
- Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 43(4), 393–402. https://doi.org/10.1097/00004583-200404000-00005
- De Los Reyes, A., & Kazdin, A. E. (2005). Informant discrepancies in the assessment of childhood psychopathology: A critical review, theoretical framework, and recommendations for further study. Psychological Bulletin, 131(4), 483–509. https://doi.org/10.1037/0033-2909.131.4.483
- Di Pierdomenico, K., Bucsea, O., Hashemi, H., Leguia, A., Lovegrove, A., Cribbie, R., & Pillai Riddell, R. (2026). Universal digital mental health interventions for children and youth: A systematic review and meta-analysis. npj Digital Medicine. https://doi.org/10.1038/s41746-026-03044-z
- Eyberg, S. M., Nelson, M. M., & Boggs, S. R. (2008). Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. Journal of Clinical Child & Adolescent Psychology, 37(1), 215–237. https://doi.org/10.1080/15374410701820117
- Henggeler, S. W., Pickrel, S. G., & Brondino, M. J. (1999). Multisystemic treatment of substance-abusing and dependent delinquents: Outcomes, treatment fidelity, and transportability. Mental Health Services Research, 1(3), 171–184. https://doi.org/10.1023/A:1022373813261
- James, A. C., Reardon, T., Soler, A., James, G., & Creswell, C. (2020). Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews, 2020(11), CD013162. https://doi.org/10.1002/14651858.CD013162.pub2
- Kendall, P. C. (1994). Treating anxiety disorders in children: Results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62(1), 100–110. https://doi.org/10.1037/0022-006X.62.1.100
- Lock, J., Le Grange, D., Agras, W. S., Moye, A., Bryson, S. W., & Jo, B. (2010). Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Archives of General Psychiatry, 67(10), 1025–1032. https://doi.org/10.1001/archgenpsychiatry.2010.128
- March, S., Spence, S. H., Myers, L., Ford, M., Smith, G., & Donovan, C. L. (2025). Integrating videoconferencing therapist guidance into stepped care internet-delivered cognitive behavioral therapy for child and adolescent anxiety: Noninferiority randomized controlled trial. JMIR Mental Health, 12, e57405. https://doi.org/10.2196/57405
- Mehlum, L., Tørmoen, A. J., Ramberg, M., Haga, E., Diep, L. M., Laberg, S., Larsson, B. S., Stanley, B. H., Miller, A. L., Sund, A. M., & Grøholt, B. (2014). Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: A randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 53(10), 1082–1091. https://doi.org/10.1016/j.jaac.2014.07.003
- Mufson, L., Weissman, M. M., Moreau, D., & Garfinkel, R. (1999). Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 56(6), 573–579. https://doi.org/10.1001/archpsyc.56.6.573
- National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE Guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations
- National Institute for Health and Care Excellence. (2019). Depression in children and young people: Identification and management (NICE Guideline NG134). https://www.nice.org.uk/guidance/ng134/chapter/Recommendations
- National Institute for Health and Care Excellence. (2022). Self-harm: Assessment, management and preventing recurrence (NICE Guideline NG225). https://www.nice.org.uk/guidance/ng225/chapter/recommendations
- Rossouw, T. I., & Fonagy, P. (2012). Mentalization-based treatment for self-harm in adolescents: A randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 51(12), 1304–1313.e3. https://doi.org/10.1016/j.jaac.2012.09.018
- Sánchez-Álvarez, N., Blanca, M. J., & Sánchez-Meca, J. (2026). Meta-analysis of psychological and digital interventions to enhance mental health and well-being in youth: A Bayesian umbrella review. Children, 13(5), 678. https://doi.org/10.3390/children13050678
- Shirk, S. R., Karver, M. S., & Brown, R. (2011). The alliance in child and adolescent psychotherapy. Psychotherapy, 48(1), 17–24. https://doi.org/10.1037/a0022181
- Sørensen, N. M., Skaarnes, H., Mathiasen, K., McLellan, L. F., Thastum, M., & Lomholt, J. J. (2026). Review: Internet-based cognitive behavioral therapy for children and adolescents with anxiety disorders—A meta-analysis of efficacy and impact of age and support. Child and Adolescent Mental Health. https://doi.org/10.1111/camh.70106
- Treatment for Adolescents With Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA, 292(7), 807–820. https://doi.org/10.1001/jama.292.7.807
- Tsujimoto, K. C., Neville, R. D., Madigan, S. L., Carere, O., Amini, J., Schumacher, A., Clarissa, S., & Korczak, D. J. (2026). Meta-analysis: The effectiveness of universal school-based mental health programs for children and adolescents. JAACAP Open, 4(5), 728–743. https://doi.org/10.1016/j.jaacop.2026.07.001
- U.S. Preventive Services Task Force. (2022). Screening for anxiety in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA, 328(14), 1438–1444. https://doi.org/10.1001/jama.2022.16936
- Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Weissman, J. S., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., Iyengar, S., March, J. S., & Kendall, P. C. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. https://doi.org/10.1056/NEJMoa0804633
- Walter, H. J., Bukstein, O. G., Abright, A. R., Keable, H., Ramtekkar, U., Ripperger-Suhler, J., & Rockhill, C. (2020). Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 59(10), 1107–1124. https://doi.org/10.1016/j.jaac.2020.05.005
- Weisz, J. R., Chorpita, B. F., Palinkas, L. A., Schoenwald, S. K., Miranda, J., Bearman, S. K., Daleiden, E. L., Ugueto, A. M., Ho, A., Martin, J., Gray, J., Alleyne, A., Langer, D. A., Southam-Gerow, M. A., Gibbons, R. D., & Research Network on Youth Mental Health. (2012). Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: A randomized effectiveness trial. Archives of General Psychiatry, 69(3), 274–282. https://doi.org/10.1001/archgenpsychiatry.2011.147
- Weisz, J. R., Kuppens, S., Ng, M. Y., Eckshtain, D., Ugueto, A. M., Vaughn-Coaxum, R., Jensen-Doss, A., Hawley, K. M., Krumholz Marchette, L. S., Chu, B. C., Weersing, V. R., & Fordwood, S. R. (2017). What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. American Psychologist, 72(2), 79–117. https://doi.org/10.1037/a0040360
- World Health Organization. (2024). Mental health of children and young people: Service guidance. https://www.who.int/publications/i/item/9789240100374